# Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor

> **NCT07433283** · PHASE1,PHASE2 · RECRUITING · sponsor: **Sichuan Enray Pharmaceutical Sciences Company** · enrollment: 54 (estimated)

## Conditions studied

- Tumor, Solid
- Lung Cancer
- Pancreas Cancer
- Thyroid Cancer
- Colorectal Cancer
- Cervical Cancer
- Vulva Cancer

## Interventions

- **DRUG:** Carbon Nanoparticle-Loaded Iron [CNSI-Fe]
- **DRUG:** Carbon Nanoparticle-Loaded Iron

## Key facts

- **NCT ID:** NCT07433283
- **Lead sponsor:** Sichuan Enray Pharmaceutical Sciences Company
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-11-12
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433283, "Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07433283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*